Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 14:eabp8966. doi: 10.1126/sciimmunol.abp8966

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works

This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 2. — Neutralization titers against SARS-CoV-2 in the patients with auto-Abs against type I IFNs. Neutralization titers against SARS-CoV-2 for healthy vaccinated donors 2-8 weeks after the second dose of mRNA vaccine (n=11), and patients with hypoxemic breakthrough COVID-19 pneumonia and auto-Abs to type I IFNs (n=10). The dashed line shows the geometric mean of healthy donor titers, the box shows interquartile range, and the shaded region is the full range. (A) Neutralization assay performed with pseudoviruses representing the D614G strain, and (B) the Delta variant (B.1.617.2).